M.F Yuen

Affiliations: 
Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong 
Area:
Mechanical Engineering
Google:
"M.F Yuen"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yuen MF, Chuang WL, Peng CY, et al. (2024) Phase 1 Trial of the Safety, Pharmacokinetics, and Antiviral Activity of EDP-514 in Untreated Viremic Chronic Hepatitis B Patients. Clinical and Molecular Hepatology
Hirode G, Hansen BE, Chen CH, et al. (2024) Limited sustained remission after nucleos(t)ide analogue withdrawal: Results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study). The American Journal of Gastroenterology
Hirode G, Hansen BE, Chen CH, et al. (2024) Erratum: Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study). The American Journal of Gastroenterology
Hou J, Gane E, Balabanska R, et al. (2024) Efficacy, safety and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients. Clinical and Molecular Hepatology
Mak LY, Hui RW, Fung J, et al. (2023) Bepirovirsen (GSK3228836) in chronic hepatitis B infection: an evaluation of phase II progress. Expert Opinion On Investigational Drugs. 1-13
Jang TY, Liang PC, Jun DW, et al. (2023) Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs. The Kaohsiung Journal of Medical Sciences
Kan K, Wong DK, Hui RW, et al. (2023) Anti-HBc: a significant host predictor of spontaneous HBsAg seroclearance in chronic hepatitis B patients - a retrospective longitudinal study. Bmc Gastroenterology. 23: 348
Kan K, Wong DK, Hui RW, et al. (2023) Plasma interferon-gamma-inducible-protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients. Journal of Gastroenterology and Hepatology
Mak LY, Hui RW, Seto WK, et al. (2023) Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid Polymers. Clinics in Liver Disease. 27: 877-893
Sonneveld MJ, Chiu SM, Park JY, et al. (2023) HBV DNA AND HBSAG LEVELS AT 24 WEEKS OFF-TREATMENT PREDICT CLINICAL RELAPSE AND HBSAG LOSS IN HBEAG NEGATIVE PATIENTS WHO DISCONTINUED ANTIVIRAL THERAPY. Gastroenterology
See more...